Brigit McLaughlin

1.8k total citations · 1 hit paper
17 papers, 932 citations indexed

About

Brigit McLaughlin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Brigit McLaughlin has authored 17 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Brigit McLaughlin's work include Prostate Cancer Treatment and Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Brigit McLaughlin is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Cancer Genomics and Diagnostics (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Brigit McLaughlin collaborates with scholars based in United States, United Kingdom and Canada. Brigit McLaughlin's co-authors include Howard I. Scher, Martin Fleisher, Nicole A. Schreiber, David Lu, Ryan Dittamore, Glenn Heller, Ryon P. Graf, Jessica Louw, Ann Johnson and Daniel C. Danila and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Virology.

In The Last Decade

Brigit McLaughlin

16 papers receiving 921 citations

Hit Papers

Association of AR-V7 on Circulating Tumor Cells as a Trea... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigit McLaughlin United States 9 682 495 330 238 109 17 932
Jessica Louw United States 9 692 1.0× 532 1.1× 479 1.5× 249 1.0× 88 0.8× 30 988
Adam Jendrisak United States 10 679 1.0× 518 1.0× 510 1.5× 255 1.1× 68 0.6× 32 988
Penelope Flohr United Kingdom 10 771 1.1× 555 1.1× 302 0.9× 439 1.8× 68 0.6× 25 1.1k
Jenny Bazov Canada 7 438 0.6× 363 0.7× 318 1.0× 358 1.5× 71 0.7× 7 986
Mateus Crespo United Kingdom 17 525 0.8× 393 0.8× 421 1.3× 399 1.7× 35 0.3× 44 1.0k
Aseem Anand United States 17 668 1.0× 313 0.6× 383 1.2× 135 0.6× 45 0.4× 33 865
Francesca Khani United States 21 685 1.0× 240 0.5× 172 0.5× 317 1.3× 19 0.2× 67 1.1k
Francesco Pepe Italy 23 890 1.3× 719 1.5× 723 2.2× 531 2.2× 28 0.3× 108 1.5k
Dzifa Y. Duose United States 16 195 0.3× 239 0.5× 170 0.5× 261 1.1× 91 0.8× 45 698
Maurizio Puccetti Italy 14 351 0.5× 198 0.4× 278 0.8× 142 0.6× 26 0.2× 44 598

Countries citing papers authored by Brigit McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Brigit McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigit McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigit McLaughlin more than expected).

Fields of papers citing papers by Brigit McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigit McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigit McLaughlin. The network helps show where Brigit McLaughlin may publish in the future.

Co-authorship network of co-authors of Brigit McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Brigit McLaughlin. A scholar is included among the top collaborators of Brigit McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigit McLaughlin. Brigit McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Flume, Patrick A., Gregory S. Sawicki, T. Pressler, et al.. (2018). WS01.2 Phase 2 initial results evaluating PTI-428, a novel CFTR amplifier, in patients with cystic fibrosis. Journal of Cystic Fibrosis. 17. S1–S2. 8 indexed citations
2.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2018). Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer. JAMA Oncology. 4(9). 1179–1179. 160 indexed citations
3.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2018). Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(6_suppl). 273–273. 7 indexed citations
4.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2017). Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. Cancer Research. 77(20). 5687–5698. 94 indexed citations
6.
Rathkopf, Dana E., Susan F. Slovin, Michael J. Morris, et al.. (2017). Targeting reciprocal feedback inhibition: Apalutamide and everolimus in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(6_suppl). 204–204. 3 indexed citations
9.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2016). Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer. European Urology. 71(6). 874–882. 129 indexed citations
10.
Pinzone, Marilia Rita, Erin H. Graf, Brigit McLaughlin, et al.. (2016). Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size. Journal of Virology. 90(23). 10436–10445. 19 indexed citations
11.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2016). AR-V7 and CTC heterogeneity biomarkers additively to predict patient (pt) outcomes with taxanes relative to approved AR targeted therapy.. Journal of Clinical Oncology. 34(15_suppl). 5013–5013. 4 indexed citations
12.
Scher, Howard I., Ryon P. Graf, Jessica Louw, et al.. (2016). Single CTC characterization to identify phenotypic and genomic heterogeneity as a mechanism of resistance to AR signaling directed therapies (AR Tx) in mCRPC patients.. Journal of Clinical Oncology. 34(2_suppl). 163–163. 2 indexed citations
13.
Scher, Howard I., Adam Jendrisak, Ryon P. Graf, et al.. (2016). CTC phenotype classifier to identify mCRPC patients (pts) with high genomic instability CTCs and to predict failure of androgen ecreptor signaling (AR Tx) and taxane (T) systemic therapies.. Journal of Clinical Oncology. 34(15_suppl). 5044–5044. 2 indexed citations
14.
Scher, Howard I., David Lu, Nicole A. Schreiber, et al.. (2016). Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer. JAMA Oncology. 2(11). 1441–1441. 461 indexed citations breakdown →
15.
McLaughlin, Brigit, Antonia C. Wells, Sam Virtue, et al.. (2010). Electrical and optical spectroscopy for quantitative screening of hepatic steatosis in donor livers. Physics in Medicine and Biology. 55(22). 6867–6879. 14 indexed citations
16.
McLaughlin, Brigit & Paul Robertson. (2009). Submillimeter Coaxial Probes for Dielectric Spectroscopy of Liquids and Biological Materials. IEEE Transactions on Microwave Theory and Techniques. 57(12). 3000–3010. 9 indexed citations
17.
McLaughlin, Brigit & Paul Robertson. (2006). Miniature open-ended coaxial probes for dielectric spectroscopy applications. Journal of Physics D Applied Physics. 40(1). 45–53. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026